POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
Main Authors: | Glaire, MA, Domingo, E, Vermeulen, L, van Wezel, T, Liefers, G-J, Lothe, RA, Nesbakkend, A, Danielsen, SA, Zlobec, I, Koelzer, V, Berger, M, Castellvi-Bel, S, de Bruyn, M, Novelli, M, Tejpar, S, Delorenzi, M, Kerr, R, Kerr, D, Tomlinson, I, Church, DN |
---|---|
Format: | Conference item |
Published: |
Oxford University Press
2016
|
Similar Items
-
Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
by: Domingo, E, et al.
Published: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
by: Van Gool, I, et al.
Published: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
by: Klenerman, P, et al.
Published: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
by: Van Gool, I, et al.
Published: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
by: Rayner, E, et al.
Published: (2016)